^
BIOMARKER:

Chr amplification(11)(q13)

News
Twitter
Trials
Chr amplification(11)(q13)
Nasopharyngeal Carcinoma
toripalimab
Resistant: C3 – Early Trials
Chr amplification(11)(q13)
Gastric Adenocarcinoma
Immunotherapy
Resistant: C3 – Early Trials